C7 peptide inhibits hepatocellular carcinoma metastasis by targeting the HGF/c-Met signaling pathway-Reference-Cited by-同舟云学术

C7 peptide inhibits hepatocellular carcinoma metastasis by targeting the HGF/c-Met signaling pathway

Published:2019-08-23 Issue:12 Volume:20 Page:1430-1442
ISSN:1538-4047
Container-title:Cancer Biology & Therapy
language:en
Short-container-title:Cancer Biology & Therapy

Author:

Zhao Mingyuan¹,Wang Yinhe¹²,Liu Yan¹,Zhang Wanchun¹²,Liu Yakun¹,Yang Xiaoming³,Cao Yunxia¹²,Wang Siying¹^ORCID

Affiliation:

1. Department of Pathophysiology, Anhui Medical University, Hefei, Anhui, P. R. China

2. Department of Gynaecology and Obstetrics, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, P. R. China

3. State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing, P. R. China

Publisher

Informa UK Limited

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/15384047.2019.1647051

Reference42 articles.

1. Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma

2. Primary liver cancer: Worldwide incidence and trends

3. Expression and mutational analysis ofMETin human solid cancers

4. Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunities

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Growth factors and their peptide mimetics for treatment of traumatic brain injury;Bioorganic & Medicinal Chemistry;2023-07

2. A comprehensive overview of knowledge graph completion;Knowledge-Based Systems;2022-11

3. A novel stemness-hypoxia-related signature for prognostic stratification and immunotherapy response in hepatocellular carcinoma;BMC Cancer;2022-10-28

4. The pathogenesis of liver cancer and the therapeutic potential of bioactive substances;Frontiers in Pharmacology;2022-10-05

5. A novel cuproptosis-related prognostic signature and potential value in HCC immunotherapy;Frontiers in Molecular Biosciences;2022-09-29